Full Text View
Tabular View
Study Results
Related Studies
A Phase I/II Clinical Study of SK&F-105517-D in Japanese Patients With Chronic Heart Failure
This study has been completed.
Study NCT00742508   Information provided by GlaxoSmithKline

First Received on August 26, 2008.   Last Updated on July 19, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Heart Failure, Congestive
Chronic Heart Failure
Additional conditions recognized in this trial
Heart Failure
More general conditions related to this trial
Cardiovascular Diseases
Heart Diseases
Interventions listed in this trial
SK&F-105517-D 10 mg capsule
SK&F-105517-D 20 mg capsule
SK&F-105517-D 40 mg capsule
Carvedilol-IR 10 mg tablet
Additional drug interventions recognized in this trial
Carvedilol
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic alpha-1 Receptor Antagonists
Adrenergic alpha-Antagonists
Adrenergic Antagonists
Adrenergic beta-Antagonists
Antihypertensive Agents
Cardiovascular Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services